Brief: Cohbar To Resume Its Phase 1A/1B Clinical Trial
03/05/2019 14:05
May 3 (Reuters) - CohBar Inc CWBR.O :
* COHBAR TO RESUME ITS PHASE 1A/1B CLINICAL TRIAL
* COHBAR INC - CONCLUDED ITS RECENT DISCUSSIONS WITH FDA AND
WILL
BE RESUMING ITS PHASE 1A/1B CLINICAL TRIAL OF CB4211
Source text for Eikon: ID:nGNX2wr7C8
Further company coverage: CWBR.O
((Briefs@thomsonreuters.com;))
Recent news on CohBar
See all newsBrief: CohBar, Inc. Q2 EPS USD -1.49
Brief: Morphogenesis And CohBar Announce Positive Results From Phase 1B Trial Of IFX-HU2.0 Personalized Cancer Vaccine, In Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) And Cutaneous Squamous Cell Carcinoma (CSCC)
U.S. STOCKS ON THE MOVE-Galecto, Pinterest, Standard Lithium
CohBar surges on merger agreement with Morphogenesis
U.S. STOCKS ON THE MOVE-Chevron, Broadcom, Williams-Sonoma